Elucidata is a bio-IT company specializing in leveraging biomedical data to accelerate drug discovery and development. Their flagship platform, Polly, is an AI-powered, cloud-based environment designed to curate, analyze, and visualize complex omics data (genomics, transcriptomics, proteomics, metabolomics). Elucidata aims to empower R&D teams in pharmaceutical and biotechnology companies by transforming massive datasets into actionable insights, thereby speeding up the journey from research to therapeutic solutions. They focus on data harmonization, FAIR data principles (Findable, Accessible, Interoperable, Reusable), and applying machine learning models to uncover biological patterns and targets.
Serves as the primary center for strategic leadership, business development, client engagement, and North American operations. It's also a hub for collaboration with the vibrant biotech ecosystem in the Cambridge/Boston area.
Located in Kendall Square, a globally recognized hub for biotechnology and pharmaceutical innovation, offering proximity to leading research institutions, venture capital, and industry partners.
Characterized by innovation, scientific rigor, and collaboration. Employees are typically engaged in cutting-edge work at the intersection of biology and data science, fostering a dynamic and intellectually stimulating environment.
The Cambridge HQ places Elucidata at the epicenter of the life sciences industry, facilitating partnerships, talent acquisition, and staying at the forefront of biomedical research and technology.
Elucidata supports a global clientele of pharmaceutical companies, biotech firms, and academic research institutions. While its physical offices are concentrated in the USA (Cambridge, MA) and India (New Delhi, Bengaluru), its cloud-based platform, Polly, and services are accessible worldwide. Their team collaborates internationally to serve customers across North America, Europe, and Asia-Pacific, providing solutions for omics data analysis and drug discovery research globally.
One Kendall Square, Building 200, Suite 2203
Cambridge
MA
USA
Address: 8th Floor, Tower A, DLF South Court, Saket, New Delhi - 110017, India
Leverages India's strong talent pool in software development and data science to drive technological innovation and support Elucidata's global operations and product roadmap.
Address: Specific street address not widely publicized, but presence in Bengaluru is noted for talent acquisition and operations.
Expands Elucidata's access to skilled professionals in India, supporting product development, data operations, and customer support functions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Elucidata' leadership includes:
Elucidata has been backed by several prominent investors over the years, including:
No major high-profile executive (C-suite direct reports to CEO) hires or exits have been broadly publicized for Elucidata in the past 12 months. The core leadership team appears stable based on public information. Companies of this size may have senior director or VP level changes that are not widely reported.
Discover the tools Elucidata uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Elucidata Corporation likely uses a standard professional email format, typically combining the employee's first name and last name, or an initial and last name, with their domain elucidata.io. This ensures consistency and professionalism in communications.
[first].[last]@elucidata.io
Format
jane.doe@elucidata.io
Example
85%
Success rate
Bio-IT World • April 26, 2023
Elucidata announced the release of PollyGPT, a generative AI tool integrated into its Polly platform. PollyGPT is designed to help scientists query and understand vast amounts of biomedical data using natural language, aiming to accelerate hypothesis generation and data analysis in drug discovery....more
PR Newswire • September 15, 2022
Elucidata secured $16 million in Series A funding led by Eight Roads Ventures and F-Prime Capital. The funding is aimed at scaling its Polly platform, expanding its team, and further developing its capabilities to help life sciences companies make better use of their biomedical data for drug discovery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Elucidata, are just a search away.